- Type / Class
- Equity / Common Stock
- Shares outstanding
- 18,303,310
- Total 13F shares
- 176,842
- Share change
- +142,108
- Total reported value
- $2,498,949
- Price per share
- $14.12
- Number of holders
- 3
- Value change
- +$2,006,565
- Number of buys
- 2
Quarterly Holders Quick Answers
What is CUSIP 690145107?
CUSIP 690145107 identifies OM - Outset Medical Inc - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 690145107:
Top shareholders of OM - Outset Medical Inc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Durable Capital Partners LP |
13D/G
13F
|
Company |
9.9%
|
26,609,101
|
$154,630,808 | $0 | 03 Jan 2025 | |
| FMR LLC |
13F
13D/G
|
Company |
14%
from 13D/G
|
2,600,385
|
$49,953,395 | — | 30 Jun 2025 | |
| PFM Health Sciences, LP |
13F
|
Company |
9.2%
|
1,664,727
|
$31,979,406 | — | 30 Jun 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
13D/G
|
Company |
0.01%
from 13D/G
|
1,623,536
|
$31,189,000 | — | 30 Jun 2025 | |
| Alyeska Investment Group, L.P. |
13F
13D/G
|
Company |
9.6%
from 13D/G
|
1,464,582
|
$28,134,620 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
13D/G
|
Company |
7.5%
from 13D/G
|
1,325,784
|
$25,468,311 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
13D/G
|
Company · The Vanguard Group |
5.6%
from 13D/G
|
991,429
|
$19,045,351 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
6.8%
from 13D/G
|
983,891
|
$18,900,546 | — | 30 Jun 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
13D/G
|
Company |
6.7%
from 13D/G
|
833,333
|
$16,008,326 | — | 30 Jun 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
3.5%
|
636,333
|
$12,223,957 | — | 30 Jun 2025 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
3%
|
549,052
|
$10,547,289 | — | 30 Jun 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
2.9%
|
521,400
|
$10,016,096 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
415,552
|
$7,984,456 | — | 30 Jun 2025 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
1.7%
|
314,522
|
$6,041,968 | — | 30 Jun 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
1.4%
|
256,682
|
$4,930,859 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.4%
|
249,358
|
$4,790,167 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.1%
|
205,270
|
$3,943,237 | — | 30 Jun 2025 | |
| Hackett Patrick T. |
3/4/5
|
Director |
1.2%
|
220,171
|
$3,368,614 | — | 02 Jun 2025 | |
| Catalio Capital Management, LP |
13F
|
Company |
0.92%
|
166,666
|
$3,201,654 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.88%
|
158,535
|
$3,045,457 | — | 30 Jun 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.79%
|
143,160
|
$2,750,104 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.75%
|
135,890
|
$2,610,447 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.67%
|
121,370
|
$2,331,517 | — | 30 Jun 2025 | |
| Renee Gaeta |
3/4/5
|
Chief Financial Officer |
0.73%
|
131,425
|
$2,010,802 | — | 10 Jun 2025 | |
| GMT CAPITAL CORP |
13F
|
Company |
0.54%
|
98,108
|
$1,884,655 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.51%
|
92,122
|
$1,769,664 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.44%
|
79,586
|
$1,528,847 | — | 30 Jun 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.41%
|
74,094
|
$1,423,346 | — | 30 Jun 2025 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
2.4%
|
429,120
|
$1,360,708 | — | 30 Jun 2025 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
0.37%
|
66,666
|
$1,281,000 | — | 30 Jun 2025 | |
| Steven S. Williamson |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
320,347
|
$1,143,639 | — | 15 Feb 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.31%
|
56,101
|
$1,077,700 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.31%
|
55,660
|
$1,069,229 | — | 30 Jun 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.29%
|
53,266
|
$1,023,240 | — | 30 Jun 2025 | |
| Jean-Olivier Racine |
3/4/5
|
Chief Technology Officer |
—
class O/S missing
|
265,325
|
$867,613 | — | 10 May 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.22%
|
39,857
|
$765,654 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.22%
|
39,617
|
$761,043 | — | 30 Jun 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.21%
|
37,247
|
$715,515 | — | 30 Jun 2025 | |
| Birchview Capital, LP |
13F
|
Company |
0.19%
|
34,584
|
$664,359 | — | 30 Jun 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.19%
|
34,495
|
$662,649 | — | 30 Jun 2025 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0.19%
|
34,547
|
$661,575 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.18%
|
32,300
|
$620,483 | — | 30 Jun 2025 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.17%
|
30,303
|
$582,121 | — | 30 Jun 2025 | |
| Susquehanna Portfolio Strategies, LLC |
13F
|
Company |
0.16%
|
29,454
|
$565,811 | — | 30 Jun 2025 | |
| Brent D. Lang |
3/4/5
|
Director |
0.19%
|
34,517
|
$528,109 | — | 02 Jun 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.14%
|
25,975
|
$498,969 | — | 30 Jun 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.14%
|
25,599
|
$492,000 | — | 30 Jun 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.13%
|
24,341
|
$464,000 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.13%
|
23,860
|
$458,351 | — | 30 Jun 2025 | |
| Verition Fund Management LLC |
13F
|
Company |
0.13%
|
23,202
|
$445,710 | — | 30 Jun 2025 |
Institutional Holders of Outset Medical Inc - Common Stock (OM) as of Q3 2025
As of 30 Sep 2025,
Outset Medical Inc - Common Stock (OM) was held by
3 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
176,842 shares.
The largest 3 holders included
GMT CAPITAL CORP, Birchview Capital, LP, and Accent Capital Management, LLC.
This page lists
3
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
2
Q3 2025 holders
3
Holder diff
1
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.